Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
19.92 USD | -0.33% | -6.02% | -20.16% |
Investment objective
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Name |
Price
|
Change
|
5d. change
|
1-year change
|
Weight
| |
---|---|---|---|---|---|---|
53.18 USD | -7.42% | -7.35% | +589.75% | +2.05% | ||
5.260 USD | -0.19% | -6.90% | -52.05% | +1.40% | ||
2.405 USD | -2.24% | -10.26% | -84.25% | +1.36% | ||
14.60 USD | -0.27% | -13.71% | +290.37% | +1.35% | ||
7.970 USD | -1.97% | -7.33% | -26.61% | +1.29% | ||
4.890 USD | +7.95% | -2.59% | -36.82% | +1.16% | ||
26.92 USD | +1.55% | -8.40% | +86.69% | +1.14% | ||
12.45 USD | -2.81% | -3.56% | -65.01% | +1.08% | ||
6.810 USD | -3.40% | -14.77% | -73.68% | +1.08% | ||
More news
Date | Price | Change | Volume |
---|---|---|---|
23-09-21 | 19.95 | -0.17% | 1,522 |
23-09-20 | 19.99 | -2.70% | 284 |
23-09-19 | 20.54 | -0.39% | 2,769 |
23-09-18 | 20.62 | -1.93% | 598 |
23-09-15 | 21.03 | -0.96% | 431 |
Other stock markets
Delayed Quote Nyse
Last update September 21, 2023 at 03:48 pm EDT
More quotesDescription
US26923G3011 | |
---|---|
Total Expense Ratio | 0.79% |
Asset Class | |
Geographical Zones | |
Sector | |
Size | |
Currency | |
Provider | |
Underlying | LifeSci Biotechnology Clinical Trials Total Return Index - USD |
Features and characteristics
Jurisdiction | |
Fund Structure | |
Replication Method | |
Replication Model | |
Date of creation |
2014-12-15
|
Dividend Policy | |
Geographical Focus |
AuM evolution ( 2023-07-30 )
Encours ($) | 11 M$ |
---|---|
AuM 1M | 11 M$ |
AuM 3 months | 10 M$ |
AuM 6 months | 15 M$ |
AuM 12 months | 17 M$ |